Journal
DIABETES
Volume 61, Issue 2, Pages 346-354Publisher
AMER DIABETES ASSOC
DOI: 10.2337/db11-0860
Keywords
-
Categories
Funding
- National Institutes of Health (NIH) [NIDDK-DK-033651, DK-063491, DK-074868]
- Eunice Kennedy Shriver National Institute of Child Health and Human Development/NIH [U54-HD-012303-25]
Ask authors/readers for more resources
Macrophage-mediated inflammation is a key component of insulin resistance; however, the initial events of monocyte migration to become tissue macrophages remain poorly understood. We report a new method to quantitate in vivo macrophage tracking (i.e., blood monocytes from donor mice) labeled ex vivo with fluorescent PKH26 dye and injected into recipient mice. Labeled monocytes appear as adipose, liver, and splenic macrophages, peaking in 1-2 days. When CCR2 KO monocytes are injected into wild-type (WT) recipients, or WT monocytes given to MCP-1 KO recipients, adipose tissue macrophage (ATM) accumulation is reduced by similar to 40%, whereas hepatic macrophage content is decreased by similar to 80%. Using WT donor cells, ATM accumulation is several-fold greater in obese recipient mice compared with lean mice, regardless of the source of donor monocytes. After their appearance in adipose tissue, ATMs progressively polarize from the M2- to the M1-like state in obesity. In summary, the CCR2/MCP-1 system is a contributory factor to monocyte migration into adipose tissue and is the dominant signal controlling the appearance of recruited macrophages in the liver. Monocytes from obese mice are not programmed to become inflammatory ATMs but rather the increased proinflammatory ATM accumulation in obesity is in response to tissue signals. Diabetes 61:346-354,2012
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available